Treatment of agnogenic myeloid metaplasi
✍
Lévy, V.; Bourgarit, A.; Delmer, A.; Legrand, O.; Baudard, M.; Rio, B.; Zittoun,
📂
Article
📅
1996
🏛
John Wiley and Sons
🌐
English
⚖ 235 KB
👁 2 views
Peripheral cytopenias are common in patients with agnogenic myeloid metaplasia (AMM). They are an important cause of morbidity and mortality, and their treatment is difficult. We report on 4 patients with AMM and severe cytopenia treated with danazol (400-600 mg/ day). Three of them became independe